BioTuesdays

Category - Markets

Exact Sciences Logo
Markets

BTIG ups Exact Sciences to buy; PT $60

BTIG upgraded Exact Sciences (NASDAQ:EXAS) to “buy” from “neutral” with a price target of $60, citing an approximate 35% drop in the stock price since November, which it said offers an “attractive entry point.” The...

April 3, 2018
Allena Pharmaceuticals Logo
Markets

Roth starts Allena Pharma at buy; PT $61

Roth Capital Partners initiated coverage of Allena Pharmaceuticals (NASDAQ: ALNA) with a “buy” rating and a $61 price target. The stock closed at $11.02 on March 29. Allena is focused on the treatment of enteric...

April 2, 2018
Flex Pharma
Markets

Ladenburg ups Flex Pharma PT to $20 from $13

Ladenburg Thalmann raised its price target for Flex Pharma (NASDAQ:FLKS) to $20 from $13 after the company announced that its lead asset, FLX-787, reduced the frequency of cramps/spasms in a 57-patient, placebo...

March 29, 2018
Revance
Markets

Needham starts Revance Therapeutics at buy; PT $42

Needham initiated coverage of Revance Therapeutics (NASDAQ:RVNC) with a “buy” rating and $42 price target. The stock closed at $30.60 on March 26. Revance is involved in the development of novel and differentiated...

March 27, 2018
Profound Medical Logo
Markets

Paradigm ups Profound Medical PT to $3

Paradigm Capital raised its price target for Profound Medical (TSXV:PRN) to $3 from $2.25 after the company completed an upsized equity financing of $34.5-million. The stock closed at $1.05 on March 20. “We see this...

March 21, 2018